Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naloxone nasal spray for problem gambling (pilot study)
2016-001828-56Phase 2Completed
- Sponsor
- Thomas H. Lee Partners
- Start
- Oct 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of naloxone in gambling disorder (GD), sponsored by Thomas H. Lee Partners. Primary endpoint: Time of gambling. Started Oct 2016; status: completed.
02
Drugs
naloxone
03
Conditions
gambling disorder (GD)
Beyond the preview
Go deeper on 2016-001828-56.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001828-56.